Cost-effectiveness of genome-wide sequencing for unexplained developmental disabilities and multiple congenital anomalies-Reference-Cited by-同舟云学术

Cost-effectiveness of genome-wide sequencing for unexplained developmental disabilities and multiple congenital anomalies

Published:2021-03 Issue:3 Volume:23 Page:451-460
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Li Chunmei^ORCID,Vandersluis Stacey,Holubowich Corinne,Ungar Wendy J.,Goh Elaine S.,Boycott Kym M.,Sikich Nancy,Dhalla Irfan,Ng Vivian

Publisher

Elsevier BV

Subject

Genetics (clinical)

Link

http://www.nature.com/articles/s41436-020-01012-w.pdf

Reference37 articles.

1. Sun F, Oristaglio J, Levy SE, Hakonarson H, Sullivan N, Fontanarosa J, et al. AHRQ comparative effectiveness technical briefs. Genetic testing for developmental disabilities, intellectual disability, and autism spectrum disorder. Rockville, MD: US Agency for Healthcare Research and Quality; 2015.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should Scotland provide genome-wide sequencing for the diagnosis of rare developmental disorders? A cost-effectiveness analysis;The European Journal of Health Economics;2024-09-09

2. Research needs for birth defect prevention and control in China in the genomic screening era;BMJ;2024-08-30

3. Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: Evidence from Canada;Genetics in Medicine;2024-04

4. Cost-Effectiveness of Whole-Genome vs Whole-Exome Sequencing Among Children With Suspected Genetic Disorders;JAMA Network Open;2024-01-26

5. Modelling and Simulation of Genomic Sequencing Platform Operations;2023 Winter Simulation Conference (WSC);2023-12-10